Circulating Tumor DNA Assessment of Disease Response in Large B-Cell Lymphoma: Lisocabtagene Maraleucel Versus Autologous Stem Cell Transplantation Standard Therapy.

Stepan L, Ansari S, Abramson JS, Okal A, Dell'Aringa J, Thompson EG, Crotta A, Chow VA, Kamdar M, Solomon SR, Johnston PB, Glass B, Mutsaers P, Arnason J, Mielke S, Shadman M, Hernandez-Ilizaliturri F, Izutsu K, Bachanova V, Ibrahimi S, Chabon JJ, Kurtz DM, Alizadeh AA, Peiser L

Open source

DOI: 10.1200/jco-25-03051
Published: 2026 Jul
Container: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/jco-25-03051,
  title = {Circulating Tumor DNA Assessment of Disease Response in Large B-Cell Lymphoma: Lisocabtagene Maraleucel Versus Autologous Stem Cell Transplantation Standard Therapy.},
  author = {Stepan L and Ansari S and Abramson JS and Okal A and Dell'Aringa J and Thompson EG and Crotta A and Chow VA and Kamdar M and Solomon SR and Johnston PB and Glass B and Mutsaers P and Arnason J and Mielke S and Shadman M and Hernandez-Ilizaliturri F and Izutsu K and Bachanova V and Ibrahimi S and Chabon JJ and Kurtz DM and Alizadeh AA and Peiser L},
  year = {2026},
  journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  doi = {10.1200/jco-25-03051},
  url = {https://doi.org/10.1200/jco-25-03051}
}

RIS

TY  - JOUR
TI  - Circulating Tumor DNA Assessment of Disease Response in Large B-Cell Lymphoma: Lisocabtagene Maraleucel Versus Autologous Stem Cell Transplantation Standard Therapy.
AU  - Stepan L
AU  - Ansari S
AU  - Abramson JS
AU  - Okal A
AU  - Dell'Aringa J
AU  - Thompson EG
AU  - Crotta A
AU  - Chow VA
AU  - Kamdar M
AU  - Solomon SR
AU  - Johnston PB
AU  - Glass B
AU  - Mutsaers P
AU  - Arnason J
AU  - Mielke S
AU  - Shadman M
AU  - Hernandez-Ilizaliturri F
AU  - Izutsu K
AU  - Bachanova V
AU  - Ibrahimi S
AU  - Chabon JJ
AU  - Kurtz DM
AU  - Alizadeh AA
AU  - Peiser L
PY  - 2026
JO  - Journal of clinical oncology : official journal of the American Society of Clinical Oncology
DO  - 10.1200/jco-25-03051
UR  - https://doi.org/10.1200/jco-25-03051
ER  -

APA

L, S., S, A., JS, A., A, O., J, D., EG, T., A, C., VA, C., M, K., SR, S., PB, J., B, G., P, M., J, A., S, M., M, S., F, H., K, I., V, B., S, I., JJ, C., DM, K., AA, A., & L, P. (2026). Circulating Tumor DNA Assessment of Disease Response in Large B-Cell Lymphoma: Lisocabtagene Maraleucel Versus Autologous Stem Cell Transplantation Standard Therapy.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. https://doi.org/10.1200/jco-25-03051

Source records

pubmed · retrieved 2026-09-27T07:31:20.473Z
europe-pmc · retrieved 2026-09-27T07:31:20.477Z